Literature DB >> 20073408

The analgesic potential of cannabinoids.

Jaseena Elikkottil1, Jaseena Elikottil, Pankaj Gupta, Kalpna Gupta.   

Abstract

Historically and anecdotally cannabinoids have been used as analgesic agents. In recent years, there has been an escalating interest in developing cannabis-derived medications to treat severe pain. This review provides an overview of the history of cannabis use in medicine, cannabinoid signaling pathways, and current data from preclinical as well as clinical studies on using cannabinoids as potential analgesic agents. Clinical and experimental studies show that cannabis-derived compounds act as antiemetic, appetite modulating, and analgesic agents. However, the efficacy of individual products is variable and dependent upon the route of administration. As opioids are the only therapy for severe pain, analgesic ability of cannabinoids may provide a much-needed alternative to opioids. Moreover, cannabinoids act synergistically with opioids and act as opioid sparing agents, allowing lower doses and fewer side effects from chronic opioid therapy. Thus, rational use of cannabis-based medications deserves serious consideration to alleviate the suffering of patients due to severe pain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20073408      PMCID: PMC3728280     

Source DB:  PubMed          Journal:  J Opioid Manag        ISSN: 1551-7489


  151 in total

1.  Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain.

Authors:  Michael Iskedjian; Basil Bereza; Allan Gordon; Charles Piwko; Thomas R Einarson
Journal:  Curr Med Res Opin       Date:  2007-01       Impact factor: 2.580

Review 2.  Endocannabinoid-mediated control of synaptic transmission.

Authors:  Masanobu Kano; Takako Ohno-Shosaku; Yuki Hashimotodani; Motokazu Uchigashima; Masahiko Watanabe
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

3.  Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury.

Authors:  Karl A Nath; Joseph P Grande; Anthony J Croatt; Elena Frank; Noel M Caplice; Robert P Hebbel; Zvonimir S Katusic
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

4.  A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats.

Authors:  David Pascual; Carlos Goicoechea; Margarita Suardíaz; María Isabel Martín
Journal:  Pain       Date:  2005-10-04       Impact factor: 6.961

5.  Cannabinoid-induced motor incoordination through the cerebellar CB(1) receptor in mice.

Authors:  K P DeSanty; M S Dar
Journal:  Pharmacol Biochem Behav       Date:  2001 May-Jun       Impact factor: 3.533

6.  Upregulation of spinal cannabinoid-1-receptors following nerve injury enhances the effects of Win 55,212-2 on neuropathic pain behaviors in rats.

Authors:  Grewo Lim; Backil Sung; Ru-Rong Ji; Jianren Mao
Journal:  Pain       Date:  2003-09       Impact factor: 6.961

7.  Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration.

Authors:  Diana L Cichewicz; Erin A McCarthy
Journal:  J Pharmacol Exp Ther       Date:  2003-03       Impact factor: 4.030

8.  Cannabis use and the risk of developing a psychotic disorder.

Authors:  Wayne Hall; Louisa Degenhardt
Journal:  World Psychiatry       Date:  2008       Impact factor: 49.548

9.  Mechanisms of morphine enhancement of spontaneous seizure activity.

Authors:  Ehsan Saboory; Miron Derchansky; Mohammed Ismaili; Shokrollah S Jahromi; Richard Brull; Peter L Carlen; Hossam El Beheiry
Journal:  Anesth Analg       Date:  2007-12       Impact factor: 5.108

10.  CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion.

Authors:  Fabrizio Montecucco; Sébastien Lenglet; Vincent Braunersreuther; Fabienne Burger; Graziano Pelli; Maria Bertolotto; François Mach; Sabine Steffens
Journal:  J Mol Cell Cardiol       Date:  2009-01-07       Impact factor: 5.000

View more
  40 in total

Review 1.  Blurred boundaries: the therapeutics and politics of medical marijuana.

Authors:  J Michael Bostwick
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

Review 2.  Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis.

Authors:  Richard S Bedlack; Nanette Joyce; Gregory T Carter; Sabrina Paganoni; Chafic Karam
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

Review 3.  Targeting novel mechanisms of pain in sickle cell disease.

Authors:  Huy Tran; Mihir Gupta; Kalpna Gupta
Journal:  Blood       Date:  2017-11-30       Impact factor: 22.113

Review 4.  The Impact of Perioperative Cannabis Use: A Narrative Scoping Review.

Authors:  Karim S Ladha; Varuna Manoo; Ali-Faizan Virji; John G Hanlon; Alexander Mclaren-Blades; Akash Goel; Duminda N Wijeysundera; Lakshmi P Kotra; Carlos Ibarra; Marina Englesakis; Hance Clarke
Journal:  Cannabis Cannabinoid Res       Date:  2019-12-06

5.  Should Medical Cannabis Administered by Inhalation Be Allowed for Hospitalized Patients?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2018-06-28

6.  Therapeutic use of cannabis: Prevalence and characteristics among adults in Ontario, Canada.

Authors:  Hayley A Hamilton; Bruna Brands; Anca R Ialomiteanu; Robert E Mann
Journal:  Can J Public Health       Date:  2017-09-14

7.  Intrathecal Injection of JWH-015 Attenuates Bone Cancer Pain Via Time-Dependent Modification of Pro-inflammatory Cytokines Expression and Astrocytes Activity in Spinal Cord.

Authors:  Cui'e Lu; Yue Liu; Bei Sun; Yu'e Sun; Bailing Hou; Yu Zhang; Zhengliang Ma; Xiaoping Gu
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

Review 8.  Comparative studies of endocannabinoid modulation of pain.

Authors:  Riley T Paulsen; Brian D Burrell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-09-23       Impact factor: 6.237

9.  Prevalence and determinants of cannabinoid prescription for the management of chronic noncancer pain: a postal survey of physicians in the Abitibi-Témiscamingue region of Quebec.

Authors:  Huguette St-Amant; Mark A Ware; Nancy Julien; Anaïs Lacasse
Journal:  CMAJ Open       Date:  2015-04-02

Review 10.  A Comprehensive Review of Cannabis in Patients with Cancer: Availability in the USA, General Efficacy, and Safety.

Authors:  Grant Steele; Tom Arneson; Dylan Zylla
Journal:  Curr Oncol Rep       Date:  2019-02-01       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.